Internal Medicine, Hematology & Oncology · Greenville, SC
NPI
1437562386
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
3 Butternut Dr Ste B
Greenville, SC, 29605
Phone (864) 241-7272
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
1,461 services
Medicare patients, 2024
352
Average age 74
Drug cost, 2024
$3.0M
1,182 prescriptions
Company payments, 2025
$1,223
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard L O'Neal was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 548 times for 237 patients. In total Richard L O'Neal billed 1,461 services in 15 codes, and Medicare paid $73K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 548 | 237 | $11.83 | $6,481 |
| 99214 Office E&M - Established | Office | 240 | 136 | $69.85 | $17K |
| 99215 Office E&M - Established | Office | 198 | 88 | $103.45 | $20K |
| 99213 Office E&M - Established | Office | 154 | 110 | $43.71 | $6,731 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 96 | 51 | $12.33 | $1,184 |
| 99215 Office E&M - Established | Facility | 34 | 26 | $107.72 | $3,662 |
| 99214 Office E&M - Established | Facility | 29 | 17 | $70.10 | $2,033 |
| 99205 Office E&M - New | Office | 25 | 25 | $135.21 | $3,380 |
| 99223 Hospital E&M - Initial | Facility | 23 | 22 | $129.59 | $2,980 |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $97.36 | $2,239 |
| 99205 Office E&M - New | Facility | 22 | 22 | $135.29 | $2,976 |
| 99204 Office E&M - New | Office | 19 | 19 | $91.13 | $1,731 |
| 99232 Hospital E&M - Subsequent | Facility | 16 | 12 | $59.00 | $944 |
| 99213 Office E&M - Established | Facility | 14 | 11 | $46.61 | $653 |
By year: 2022 $73K for 909 services; 2023 $65K for 850 services; 2024 $73K for 1,461 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard L O'Neal prescribed most often to Medicare patients was Eliquis (Apixaban), with 84 prescriptions and refills. In total Richard L O'Neal wrote 1,182 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 84 | 93 | 16 | $53K |
| Prednisone Generic | 68 | 81 | 34 | $219 |
| Xarelto Rivaroxaban | 48 | 62 | Under 11 | $34K |
| Levothyroxine Sodium Generic | 45 | 110 | 17 | $279 |
| Oxycodone Hcl Generic | 44 | 44 | 24 | $957 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 36 | 36 | 18 | $897 |
| Dexamethasone Generic | 33 | 33 | 16 | $208 |
| Olanzapine Generic | 31 | 31 | Under 11 | $297 |
| Hydroxyurea Generic | 30 | 66 | Under 11 | $1,680 |
| Anastrozole Generic | 30 | 87 | 12 | $703 |
| Lorazepam Generic | 29 | 29 | 13 | $75.89 |
| Tabrecta Capmatinib Hydrochloride | 28 | 28 | Under 11 | $613K |
| Pantoprazole Sodium Generic | 28 | 48 | Under 11 | $303 |
| Furosemide Generic | 28 | 39 | 17 | $63.6 |
| Ondansetron Odt Ondansetron | 26 | 27 | 15 | $341 |
Brand drugs: 342 claims; generic drugs: 840 claims; opioid claims: 107.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard L O'Neal $1,223 ($1,223 in general payments such as food, travel and fees) from 20 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $242.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $242 |
| Lilly USA, LLC LLY | 4 | $163 |
| Gilead Sciences, Inc. GILD | 3 | $153 |
| BeOne Medicines USA, Inc. ONC | 1 | $125 |
| Daiichi Sankyo Inc. 4568.T | 4 | $95.87 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $73.52 |
| Janssen Biotech, Inc. JNJ | 2 | $70.51 |
| Taiho Oncology, Inc. 4578.T | 2 | $52.55 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $27.9 |
| Merck Sharp & Dohme LLC MRK | 1 | $27.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.